Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-018419
Filing Date
2007-03-13
Accepted
2007-03-13 06:02:43
Documents
16
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-3746_110k.htm 10-K 1916798
2 EX-10.2 a07-3746_1ex10d2.htm EX-10.2 140646
3 EX-10.3 a07-3746_1ex10d3.htm EX-10.3 90751
4 EX-10.4 a07-3746_1ex10d4.htm EX-10.4 90599
5 EX-10.19 a07-3746_1ex10d19.htm EX-10.19 348696
6 EX-10.32 a07-3746_1ex10d32.htm EX-10.32 597549
7 EX-10.34 a07-3746_1ex10d34.htm EX-10.34 59721
8 EX-23.1 a07-3746_1ex23d1.htm EX-23.1 2051
9 EX-31.1 a07-3746_1ex31d1.htm EX-31.1 9951
10 EX-31.2 a07-3746_1ex31d2.htm EX-31.2 9903
11 EX-32 a07-3746_1ex32.htm EX-32 12378
12 GRAPHIC g37462kd01i001.gif GRAPHIC 82
13 GRAPHIC g37461dgi001.gif GRAPHIC 22026
14 GRAPHIC g37461dki001.gif GRAPHIC 24203
15 GRAPHIC g37461dwi001.gif GRAPHIC 8986
16 GRAPHIC g37461dii001.jpg GRAPHIC 57160
  Complete submission text file 0001104659-07-018419.txt   3435937
Mailing Address
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
METABASIS THERAPEUTICS INC (Filer) CIK: 0001053221 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50785 | Film No.: 07689242
SIC: 2834 Pharmaceutical Preparations